Profound Medical（纳斯达克股票代码：PROF）报告季度每股亏损$(0.20)，优于分析师共识预期的$(0.33)，超过预期39.39%。这比去年同期每股亏损$(0.42)增加了52.38%。公司报告季度销售额为418万美元，不及分析师共识预期的427万美元，相差2.10%。这比去年同期的200万美元销售额增加了108.85%。

以上内容来自Benzinga Earnings专栏，原文如下：

Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.33) by 39.39 percent. This is a 52.38 percent increase over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $4.18 million which missed the analyst consensus estimate of $4.27 million by 2.10 percent. This is a 108.85 percent increase over sales of $2.00 million the same period last year.